Healthy Skepticism Library item: 10632

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Breggin PR.
Fluvoxamine as a cause of stimulation, mania, and aggression: A critical analysis of the FDA-approved label
Ethical Human Sciences and Services 2002; 4:(3):211-227

Abstract:

The contents of the FDA-approved label for Luvox (fluvoxamine) are compared to the known risks of fluvoxamine-induced stimulation, mania, and aggression in children and adults. It is found that the label in many ways fails to communicate the severity and range of these drug-induced adverse mental and behavioral drug effects. Health professionals need to approach government-approved labels with skepticism and scientific sophistication, especially in regard to evaluating the risks of medications.